Saturn V Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Saturn V Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-341,827	Closed	-$6.86M	–	20
2022 Q4	$6.86M	Buy	+341,827	New	+$7.22M	5.7%	9

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Saturn V Capital Management's ALBO Position: Q1 2023 in Review

Saturn V Capital Management sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 341,827 shares — an estimated $6.86M sold.

Saturn V Capital Management first reported a position in ALBO in Q4 2022 and held it in 1 quarter. The position peaked at $6.86M in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Saturn V Capital Management reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Saturn V Capital Management sold 341,827 Albireo Pharma Inc shares in Q1 2023, an estimated $6.86M.
Saturn V Capital Management first reported a position in Albireo Pharma Inc in Q4 2022 and held it in 1 quarter.
Saturn V Capital Management's Albireo Pharma Inc position peaked at $6.86M in Q4 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Saturn V Capital Management's 13F filing for Q1 2023, filed 15 May 2023.